Ketoprofen News
The Endo a CEO
If only all pharmaceutical stock price gains were so easy. Shares of Endo Pharmaceuticals (NYSE: ENDP) rose more than 7% yesterday after its CEO Peter Lankau resigned.
TheraQuest Receives $3 Million in Equity Investment and Licensing Fees from Wonpung
TheraQuest Biosciences, Inc., a development stage pain management company today announced that it has completed a $3 million licensing and equity investment transaction with Wonpung Mulsan Co., LTD.
Ketoprofen is more effective than tramadol for analgesia during early recovery after tonsillectomy in children
According to a study from Finland, "Pain following tonsillectomy is often intense. Nonsteroidal anti-inflammatory drugs and opioids are effective, but both can cause adverse effects. Tramadol may be a viable alternative for...
IDEA AG announces successful completion of its pivotal Ph III study in Europe and reacquisition of rights to the targeted analgesic IDEA-033 in North America
IDEA AG today reports the positive outcome of another pivotal Phase III efficacy and safety study of the targeted analgesic product IDEA-033 in osteoarthritis (OA) of the knee in Europe.
TheraQuest Presents Postsurgical Pain Results at the American Pain Society Meeting in Boston
TheraQuest Biosciences, a development stage pain management company, today unveiled new, positive Phase II clinical trial results for its intravenous ketoprofen (TQ-1011) product at the American Pain Society 24th Annual...